Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE2081.752.05 (+0.1 %)
PREV CLOSE () 2079.70
OPEN PRICE () 2063.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1788
TODAY'S LOW / HIGH ()2063.45 2103.50
52 WK LOW / HIGH ()1240.55 2355.05
NSE2085.406.55 (+0.32 %)
PREV CLOSE() 2078.85
OPEN PRICE () 2078.85
BID PRICE (QTY) 2085.40 (2)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 34465
TODAY'S LOW / HIGH() 2069.15 2107.95
52 WK LOW / HIGH ()1246.75 2353.95
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1979

Management Info :

Mannalal B Agrawal - Chairman Yogesh M Agrawal - Managing Director

Registered Office :

Address : Ajanta House,Charkop ,Kandivali (W),
Mumbai,
Maharashtra-400067

Phone : 022-66061000

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
15Apr Ajanta Pharma informs about compliance
Ajanta Pharma has informed that it enclosed Compliance Certificate - Reg..
30Mar Ajanta Pharma informs about disclosure
Ajanta Pharma has informed that the exchange has received Disclosure und..
31Jan Cancellation Of Employee Stock Option
Please note that the Nomination and Remuneration Committee of the Board..
25Jan Ajanta Pharma informs about update on
With reference to its letter dated 19th January 2024, informing about th..
25Jan Ajanta Pharma submits intimation of re
With reference to letter dated 19th January 2024, informing about the Bo..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit2201.55587.19999999999
Gross Profit 3051.4 6998.49999999999
Operating Profit 3409.18320.29999999999
Net Sales 10852.934112.7
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Bharat Parenterals (BSE)
 1455.20 (10.00%)
M.Cap ( in Cr)
846.88
Solara Active Pharma (BSE)
 551.45 (16.32%)
M.Cap ( in Cr)
1985.01
Abbott India (BSE)
 26131.85 (0.29%)
M.Cap ( in Cr)
55528.36
Windlas Biotech (BSE)
 555.05 (6.97%)
M.Cap ( in Cr)
1154.42
Concord Biotech (BSE)
 1595.25 (1.05%)
M.Cap ( in Cr)
16688.90
Shareholding Pattern
PROMOTERS 66.21%
MUTUAL FUNDS/UTI 14.76%
NON-INSTITUTION 7.76%
FI/BANKS/INSURANCE 2.16%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX73088.33599.34 (0.83%)
NIFTY22147.00151.15 (0.69%)
Dow Jones 37775.3822.07 (0.06%)
Nasdaq 15601.50-81.87 (-0.52%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI